IRWD
Ironwood Pharmaceuticals Inc
3.60$
-3.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +3.4% | -36.3% | +26.1% | -3.0% | -1.1% | -54.6% | +107.2% | +43.2% | -60.9% | +123.2% | +6.1% | – | |
| – | +1.0% | +4,942.0% | -98.0% | +5,794.7% | +163.1% | -65.0% | -98.3% | +1.7% | -3.2% | -3.7% | – | – | |
| – | +3.8% | -58.3% | +92.4% | -34.6% | +46.6% | -84.9% | +518.3% | +43.4% | -60.8% | +122.3% | +6.6% | – | |
| – | +10.5% | -27.6% | +17.7% | -1.8% | -14.9% | +8.0% | -16.5% | -4.0% | -0.6% | -1.7% | +4.3% | – | |
| – | +7.3% | -2.7% | -1.7% | -2.3% | -7.0% | -27.8% | -30.8% | +30.4% | -11.9% | -37.6% | -6.0% | – | |
| – | +23.7% | -52.4% | +82.5% | -48.0% | +63.5% | -27.5% | -7.3% | +10.6% | -6.3% | -18.5% | +0.6% | – | |
| – | -22.7% | -70.7% | +126.7% | +2.6% | +22.8% | -192.4% | – | +72.4% | -91.6% | +1,006.9% | +9.3% | – | |
| – | -14.4% | -14.2% | +3.3% | +26.1% | -5.4% | -9.5% | +3.5% | +0.9% | -6.5% | +15.9% | -21.2% | – | |
| – | -4.9% | -83.7% | +280.7% | -8.0% | +38.1% | -251.2% | – | +79.8% | -99.3% | +14,223.5% | +13.1% | – | |
| – | +78.5% | -71.6% | +116.4% | -30.5% | +58.4% | -94.9% | +1,176.8% | +96.4% | -90.2% | +793.4% | -8.0% | – | |
| – | -107.1% | – | – | – | -38.1% | -1,757.2% | – | +69.8% | -105.7% | – | +25.8% | – | |
| – | -4.1% | -70.5% | +124.3% | +1.6% | +22.3% | -130.2% | – | +64.9% | -88.6% | +749.4% | +8.3% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.